New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News Pod is a Woman: Breast Cancer Awareness Pod is a Woman News | October 2020 Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers JCO Precision Oncology News | September 2020 Olaparib and Durvalumab in Patients with Germline BRCA-Mutated Metastatic Breast Cancer The Lancet News | August 2020 Study Finds New Mutation in Ashkenazi Jews Jewish Exponent News | July 2020 Study Finds New Mutation in Ashkenazi Jews Jewish Exponent News | July 2020 Genetic Counseling for Cancer Shifts to a New Era of Virtual Care Cure Magazine News | June 2020 Angela R. Bradbury, MD, on Telemedicine in Genetic Counseling Cancer Network News | May 2020 When Isolation is Worse Than Death: a Philly Oncologist on Cancer Patients and COVID-19 l Opinion Philadelphia Inquirer News | May 2020 EMBRACA Trial Shows No Overall Survival Difference Between Talzenna, Chemotherapy Arms Precision Oncology News News | April 2020 Genetic Testing Leads Me to a PARP Inhibitor Trial Let's Win! Pancreatic Cancer News | April 2020 Positron Emission Tomography Imaging of Poly–(Adenosine Diphosphate–Ribose) Polymerase 1 Expression in Breast Cancer Journal of the American Medical Association News | April 2020 Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families Journal of Clinical Oncology News | April 2020 PARP Inhibitor Drugs Can Be ‘Tuned’ for Better Killing of Tumor Cells Penn Today News | April 2020 Structural Basis for Allosteric PARP-1 Retention on DNA Breaks Science News | April 2020 PARP inhibitor drugs can be ‘tuned’ for better killing of tumor cells Penn Today News | April 2020 Working on ‘The Human Side’ of Heritable Cancers Penn Today News | March 2020 Penn is Fighting Pancreatic Cancer Penn Today News | March 2020 Loss-of-Function Variants in CTNNA1 Detected on Multigene Panel Testing in Individuals with Gastric or Breast Cancer Nature News | February 2020 Pagination First page« First Previous page‹‹ … Page8 Page9 Page10 Page11 Current page12 Page13 Page14 Page15 Page16 … Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers JCO Precision Oncology News | September 2020
Olaparib and Durvalumab in Patients with Germline BRCA-Mutated Metastatic Breast Cancer The Lancet News | August 2020
When Isolation is Worse Than Death: a Philly Oncologist on Cancer Patients and COVID-19 l Opinion Philadelphia Inquirer News | May 2020
EMBRACA Trial Shows No Overall Survival Difference Between Talzenna, Chemotherapy Arms Precision Oncology News News | April 2020
Positron Emission Tomography Imaging of Poly–(Adenosine Diphosphate–Ribose) Polymerase 1 Expression in Breast Cancer Journal of the American Medical Association News | April 2020
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families Journal of Clinical Oncology News | April 2020
Loss-of-Function Variants in CTNNA1 Detected on Multigene Panel Testing in Individuals with Gastric or Breast Cancer Nature News | February 2020
